Percepta Genomic Sequencing Classifier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Veracyte (VCYT) Announces Publication of Data Validating Clinical Performance of Veracyte s Percepta Genomic Sequencing Classifier in Lung Cancer Diagnosis

Veracyte (VCYT) Announces Publication of Data Validating Clinical Performance of Veracyte s Percepta Genomic Sequencing Classifier in Lung Cancer Diagnosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Giuliac kennedyVeracyte incPercepta genomic sequencing classifierBill bulmanPercepta registry

Zacks: Analysts Anticipate Veracyte, Inc (NASDAQ:VCYT) Will Post Quarterly Sales of $67 37 Million

Equities analysts forecast that Veracyte, Inc. (NASDAQ:VCYT – Get Rating) will announce sales of $67.37 million for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Veracyte’s earnings. The highest sales estimate is $69.01 million and the lowest is $65.50 million. Veracyte reported sales of $55.11 million during the same […]

New zealand generalNew zealandRaymond jamesZacks investment researchNorges bankWellington management groupVeracyte incVeracyte company profile get ratingInvestment managementGet ratingInvestment researchManagement groupStreet corpCompany profileAfirma genomic sequencing classifierExpression atlas

Veracyte, Inc (NASDAQ:VCYT) Expected to Announce Earnings of -$0 18 Per Share

Analysts expect Veracyte, Inc. (NASDAQ:VCYT – Get Rating) to post ($0.18) earnings per share for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Veracyte’s earnings, with the highest EPS estimate coming in at ($0.08) and the lowest estimate coming in at ($0.24). Veracyte posted earnings of ($0.13) per share during […]

Hong kongNeedham companyZacks investment researchVeracyte incFirst horizon advisors incLazard asset managementHong kong ltdGet ratingInvestment researchStreet capitalIvy capital managementKong ltdHorizon advisorsAsset managementAfirma genomic sequencing classifierExpression atlas

Veracyte, Inc (NASDAQ:VCYT) Expected to Post Quarterly Sales of $61 98 Million

Analysts expect that Veracyte, Inc. (NASDAQ:VCYT – Get Rating) will report sales of $61.98 million for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Veracyte’s earnings. The lowest sales estimate is $60.60 million and the highest is $63.73 million. Veracyte posted sales of $36.70 million in the same quarter last […]

New zealand generalNew zealandGiuliac kennedySecurities exchange commissionZacks investment researchWellington management groupBlackrock incInvesco ltdInvestment managementArtisan partners limited partnershipVeracyte incVeracyte company profile get ratingGet ratingInvestment researchStreet capitalExchange commission

Veracyte, Inc (NASDAQ:VCYT) Expected to Post Quarterly Sales of $61 98 Million

Analysts expect Veracyte, Inc. (NASDAQ:VCYT – Get Rating) to announce sales of $61.98 million for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Veracyte’s earnings. The lowest sales estimate is $60.60 million and the highest is $63.73 million. Veracyte reported sales of $36.70 million during the same quarter last […]

Giuliac kennedyRaymond jamesSecurities exchange commissionZacks investment researchFirst horizon advisors incLazard asset managementNeedham companyFinancial services group incVienna asset managementVeracyte incGet ratingZacks investmentInvestment researchStreet capitalExchange commissionIvy capital management